Cerba Healthcare
Cerba Healthcare, a leading player in the global healthcare sector, is headquartered in France and operates extensively across Europe, Africa, and the Asia-Pacific region. Founded in 1967, the company has established itself as a pioneer in laboratory medicine and diagnostics, providing innovative solutions that enhance patient care. Specialising in clinical pathology, Cerba Healthcare offers a comprehensive range of laboratory services, including biomarker testing and genetic analysis. Their commitment to quality and precision sets them apart in the industry, ensuring accurate results that healthcare professionals can trust. With a strong market position, Cerba Healthcare has achieved significant milestones, including strategic partnerships and expansions that bolster its reputation as a trusted provider in the healthcare landscape. Their dedication to advancing medical science and improving patient outcomes continues to drive their success.
DitchCarbon Score
How does Cerba Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cerba Healthcare's score of 29 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cerba Healthcare's reported carbon emissions
In 2023, Cerba Healthcare reported total carbon emissions of approximately 339,011 tonnes CO2e. This figure includes 12,879 tonnes CO2e from Scope 1 emissions, 6,131 tonnes CO2e from Scope 2 emissions, and a significant 320,000 tonnes CO2e from Scope 3 emissions, which primarily stem from purchased goods and services, upstream transportation, and waste generated in operations. Cerba Healthcare has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions from purchased goods and services within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to global efforts to limit temperature rise to 1.5°C. The company's emissions data reflects a proactive approach to sustainability within the healthcare sector, highlighting its commitment to reducing its carbon footprint and addressing climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 7,730,000 | - | 00,000,000 |
| Scope 2 | 4,091,000 | - | 0,000,000 |
| Scope 3 | 677,284,000 | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cerba Healthcare is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
